Dr. Reddy's Laboratories Limited (RDDA) — Cash Flow Reinvestment Rate
Dr. Reddy's Laboratories Limited (RDDA) has a Cash Flow Reinvestment Rate of 0.99x as of December 2025, reinvesting €10.80 Billion (capex €7.32 Billion plus investments €-3.48 Billion) from operating cash flow of €10.91 Billion. Check RDDA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dr. Reddy's Laboratories Limited Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Dr. Reddy's Laboratories Limited across 9 annual periods. Explore RDDA long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year capital reinvestment analysis for Dr. Reddy's Laboratories Limited. For live market cap and broader valuation context, see Dr. Reddy's Laboratories Limited stock valuation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.28x | €59.52 Billion | €46.43 Billion | €34.40 Billion | ▼ -14.0% |
| 2024 | 1.49x | €67.72 Billion | €45.43 Billion | €27.43 Billion | ▲ +45.7% |
| 2023 | 1.02x | €60.24 Billion | €58.88 Billion | €18.87 Billion | ▲ +11.2% |
| 2022 | 0.92x | €25.86 Billion | €28.11 Billion | €14.66 Billion | ▲ +137.2% |
| 2021 | 0.39x | €13.85 Billion | €35.70 Billion | €9.74 Billion | ▲ +128.8% |
| 2020 | 0.17x | €5.06 Billion | €29.84 Billion | €4.85 Billion | ▼ -47.3% |
| 2019 | 0.32x | €9.24 Billion | €28.70 Billion | €6.96 Billion | ▼ -57.6% |
| 2018 | 0.76x | €13.68 Billion | €18.03 Billion | €9.29 Billion | ▼ -52.2% |
| 2017 | 1.59x | €34.14 Billion | €21.51 Billion | €12.28 Billion | — |